Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period

Abstract

Early poliovirus vaccines, both inactivated and live attenuated, were inadvertently contaminated with simian virus 40 (SV40), a monkey virus known to be oncogenic for newborn hamsters. Although large epidemiologic studies have not identified an elevated cancer risk in persons who received SV40-contaminated vaccines, fragments of SV40 DNA have recently been identified in certain human tumours. We report the follow-up of a cohort of 1073 persons, unique because they received SV40-contaminated poliovirus vaccines as newborns in 1961–63. A previous report of the status of these subjects as of 1977–79 identified 15 deaths, none due to cancer. The present study utilized the National Death Index to identify deaths in the cohort for the years 1979–96. Expected deaths were calculated from Cleveland area sex-, age-, race- and year-specific mortality rates. Increased mortality from all causes was not found. 4 deaths from cancer were found compared to 3.16 expected (P= 0.77). However, 2 deaths from testicular cancer occurred, compared to 0.05 expected (P= 0.002), which may be a chance finding due to multiple comparisons. There were 2 deaths due to leukaemia, a non-significant finding, and no deaths due to tumours of the types putatively associated with SV40. Although these results are, for the most part, consistent with other negative epidemiologic investigations of risks from SV40-contaminated vaccines, further study of testicular cancer may be warranted, and it will be important to continue monitoring this cohort which is now reaching middle-age. © 2001 Cancer Research Campaign www.bjcancer.com

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Butel JS and Lednicky JA (1999) Review. Cell and molecular biology of Simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91: 119–134

  2. Carbone M, Pass HI, Rizzo P, Marinetti MR, DiMuzio M, Mew DJP, Levine AS and Procopio A (1994) Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781–1790

  3. Diamandopoulos GTh (1972) Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by Simian virus 40. Science 176: 173–175

  4. Fraumeni JF, Stark CR, Gold E and Lepow ML (1970) Simian virus 40 in polio vaccine: follow-up of newborn recipients. Science 167: 59–60

  5. Geissler E (1990) SV40 and human brain tumors. Prog Med Virol 37: 211–222

  6. Gerber P, Hottle GA and Grubbs RE (1961) Inactivation of vacuolating virus (SV40) by formaldehyde. Proc Soc Exp Biol Med 108: 205–209

  7. Hennekens CH and Buring JE (1987) Epidemiology in Medicine. Little Brown: Boston

  8. Lepow ML, Warren RJ, Ingram VG, Daugherty SC and Robbins FC (1962) Sabin type 1 oral poliomyelitis vaccine: effect of dose upon response of newborn infants. Am J Dis Child 104: 67–71

  9. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G and Tognon M (1996) SV40 region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Research 56: 4820–4825

  10. Martini F, Dolcetti R, Gloghini A, Iacherri L, Carbone A, Boiocchi M and Tognon M (1998) Simian-virus-40 footprints in human lymphoproliferative disorders of HIV– and HIV+ patients. Int J Cancer 78: 669–674

  11. Mortimer EA Jr., Lepow ML, Gold E, Robbins FC, Burton GJ and Fraumeni JF Jr. (1981) Longterm follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 305: 1517–1518

  12. Olin P and Geisecke J (1998) Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993. In Brown F, Lewis AMSimian virus 40 (SV40): A possible human polyomavirus. Dev Biol Stand 94: 227–233

  13. Patterson BH and Bilgrad R (1986) Use of the National Death Index in cancer studies. J Natl Cancer Inst 77: 877–881

  14. Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LV, Powers A, DiResta I, Alkan S, Pass HI and Fisher RI (1999) Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin’s lymphoma. Chest 116: 470S–473S

  15. Shah K and Nathanson N (1976) Human exposure to SV40: review and comment. Am J Epidemiol 103: 1–12

  16. Shah KV, Daniel RW, Strickler HD and Goedert JJ (1997) Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis, 1618–1621

  17. Stenton SC (1998) Editorial. Simian virus 40 and human malignancy. BMJ 316: 877

  18. Strickler HD and Goedert JJ (1998) Exposure to SV40-contaminated poliovirus vaccine and the risk of cancer-A review of the epidemiological evidence. Dev Biol Stand 94: 235–244

  19. Strickler HD, Goedert JJ, Fleming M, Travis WD, Williams AE, Rabkin CS, Daniel RW and Shah KV (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 5: 473–475

  20. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr., and Goedert JJ (1998) Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA 279: 292–295

  21. Sweet BH and Hilleman MR (1960) The vacuolating virus, SV40. Proc Soc Exp Biol Med 105: 420–427

Download references

Author information

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Carroll-Pankhurst, C., Engels, E., Strickler, H. et al. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br J Cancer 85, 1295–1297 (2001). https://doi.org/10.1054/bjoc.2001.2065

Download citation

Keywords

  • SV40
  • poliovirus vaccines
  • cancer
  • newborns

Further reading